Artesunate Injection, Powder, For Solution
NDC Package 73607-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Artesunate injection is a human prescription drug. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Amivas, Inc, this product is identified by NDC 73607-002.

Identification & Billing

NDC Package Code
73607-002-01
Package Description
1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product Code
73607-002
11-Digit Billing Format
73607000201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Artesunate
Non-Proprietary Name
Artesunate
Substance Name
Artesunate
Dosage Form
Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
Active Ingredient(s)
ARTESUNATE 110 mg/1

Regulatory & Marketing

Labeler Name
Amivas, Inc
Product Type
Human Prescription Drug
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
12-11-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73607-002-01 identifies a specific commercial package of 1 injection, powder, for solution in 1 vial of Artesunate (UNFINISHED drug), a human prescription drug labeled by Amivas, Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, for solution is formulated for use and contains artesunate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amivas, Inc on December 11, 2020. The current certification is valid through December 31, 2026.

How is this Amivas, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73607000201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73607-002-01
11-Digit CMS (5-4-2)
73607-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.